scholarly journals Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories

2019 ◽  
Vol 6 (7) ◽  
pp. 541-546 ◽  
Author(s):  
Christopher A. Ross ◽  
Ralf Reilmann ◽  
Francisco Cardoso ◽  
Elizabeth A. McCusker ◽  
Claudia M. Testa ◽  
...  
Keyword(s):  
Huntington's Disease ◽  
Movement Disorder ◽  
Huntington’S Disease ◽  
Task Force ◽  
Diagnostic Categories ◽  
Movement Disorder Society

Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria

2011 ◽  
Vol 17 (8) ◽  
pp. 621-624 ◽  
Author(s):  
P. Martinez-Martin ◽  
C. Falup-Pecurariu ◽  
C. Rodriguez-Blazquez ◽  
M. Serrano-Dueñas ◽  
F.J. Carod Artal ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Movement Disorder ◽  
Task Force ◽  
Movement Disorder Society

scholarly journals Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force

2019 ◽  
Vol 34 (11) ◽  
pp. 1602-1613 ◽  
Author(s):  
Sterre Veen ◽  
Rodi Zutt ◽  
Christine Klein ◽  
Connie Marras ◽  
Samuel F. Berkovic ◽  
...  
Keyword(s):  
Movement Disorder ◽  
Task Force ◽  
Genetically Determined ◽  
Movement Disorder Society

scholarly journals Westphal Variant of Huntington's Disease

2017 ◽  
Vol 17 (01) ◽  
pp. 028-030
Author(s):  
L. Cabarcas-Castro ◽  
J. Ramón-Gómez ◽  
A. Zarante-Bahamón ◽  
O. Bernal-Pacheco ◽  
E. Espinosa-García ◽  
...  
Keyword(s):  
Family History ◽  
Huntington's Disease ◽  
Movement Disorder ◽  
Huntington’S Disease ◽  
Neurodegenerative Disorder ◽  
Cag Repeats ◽  
Molecular Evidence ◽  
Exon 1 ◽  
History Of

AbstractA Westphal variant of Huntington's disease (HD) is an infrequent presentation of this inherited neurodegenerative disorder. Here, we describe a 14-year-old girl who developed symptoms at the age of 7, with molecular evidence of abnormally expanded Cytosine-Adenine-Guanine (CAG) repeats in exon 1 of the Huntingtin gene. We briefly review the classical features of this variant highlighting the importance of suspecting HD in a child with parkinsonism and a family history of movement disorder or dementia.

scholarly journals Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

2007 ◽  
Vol 22 (16) ◽  
pp. 2314-2324 ◽  
Author(s):  
Bruno Dubois ◽  
David Burn ◽  
Christopher Goetz ◽  
Dag Aarsland ◽  
Richard G. Brown ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Movement Disorder ◽  
Task Force ◽  
Diagnostic Procedures ◽  
Parkinson’S Disease Dementia ◽  
Movement Disorder Society

scholarly journals Worsening of movement disorder following treatment with electroconvulsive therapy in a patient with Huntington’s disease

2019 ◽  
Vol 12 (8) ◽  
pp. e230389 ◽  
Author(s):  
Hesitha Abeysundera ◽  
Allan Campbell ◽  
Shanthi Sarma
Keyword(s):  
Case Report ◽  
Huntington's Disease ◽  
Movement Disorder ◽  
Huntington’S Disease ◽  
Electroconvulsive Therapy ◽  
Movement Disorders ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Medical Practitioners ◽  
Resistant Depression

This paper describes a patient who presented with treatment-resistant depression with comorbid anxiety symptoms in the context of Huntington’s disease (HD) and developed worsening movement disorder symptoms after commencing electroconvulsive therapy (ECT) for depression. The aim of this case report is to provide medical practitioners with a greater awareness of the possibility of worsening movement disorders when using ECT for depression in a patient with HD.

Neuropsychologische Verlaufsdiagnostik bei Parkinson-Patienten – Darstellung kritischer Test-Retestdifferenzen für die Einzelfalldiagnostik

2013 ◽  
Vol 24 (4) ◽  
pp. 253-266 ◽  
Author(s):  
Hubert Ringendahl
Keyword(s):  
Movement Disorder ◽  
Task Force ◽  
Movement Disorder Society

Zu mehreren von der „Movement Disorder Society Task Force” ( Litvan et al., 2012 ) empfohlenen und weiteren in der Parkinson-Diagnostik bewährten neuropsychologischen Testverfahren werden kritische Test-Retest-Differenzen dargestellt. Diese ermöglichen es, die Wirksamkeit therapeutischer Maßnahmen bzw. den allgemeinen Krankheitsverlauf bzgl. neuropsychologischer Variablen im Einzelfall statistisch zu überprüfen. Da für einige Verfahren die für Berechnung kritischer Test-Retestdifferenzen notwendigen Testdaten fehlen bzw. nur von sehr jungen Probanden vorliegen oder für den deutschen Sprachraum gar nicht vorhanden sind, werden entsprechende Untersuchungen bei Parkinson-Patienten angeregt.

Sign in / Sign up

Export Citation Format

Share Document